Rituximab-Lenalidomide(R2) Maintenance Is Superior to Rituximab Maintenance After First Line Immunochemotherapy in Mantle Cell Lymphoma: Results of the Mcl R2 Elderly Clinical Trial

AuthID
 P-00X-4CM
24
Author(s)
Ribrag, V
·
Safar, V
·
Kluin Nelemans, H
·
Casasnovas, O
·
Thieblemont, C
·
Daguindau, N
·
Damaj, GL
·
[+4]·
da Silva, MG
·
Marin Niebla, A
·
Taszner, M
·
Walewski, J
·
Boersma, R
·
Delfau Larue, MH
·
Le Gouill, S
·
Dreyling, MH
View all authors
Tipo de Documento
Abstract
Year published
2021
Publicado
in BLOOD, ISSN: 0006-4971
Volume: 138
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000736398801155
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.
All authors
Name Order Nome   Name Order Nome   Name Order Nome
1 Ribrag, V;   2 Safar, V;   3 Kluin Nelemans, H;
4 Oberic, L;   5 Feugier, P;   6 Casasnovas, O;
7 Thieblemont, C;   8 Daguindau, N;   9 Damaj, GL;
10 Klapper, W;   11 Hoster, E;   12 von Weikersthal, LF;
13 Haenel, M;   14 Andre, M;   15 da Silva, MG;
16 Carcinero, F;   17 Marin Niebla, A;   18 Taszner, M;
19 Walewski, J;   20 Boersma, R;   21 Houtenbos, I;
22 Delfau Larue, MH;   23 Le Gouill, S;   24 Dreyling, MH;

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service